𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995–2004)

✍ Scribed by Yiqun Chen; Zhenguo Qiu; Anmmd Kamruzzaman; Tom Snodgrass; Andrew Scarfe; Heather E. Bryant

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
130 KB
Volume
18
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Panitumumab monotherapy in patients with
Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer
✍ J. Randolph Hecht; Amita Patnaik; Jordan Berlin; Alan Venook; Imtiaz Malik; Simo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

## Abstract ## BACKGROUND. The safety and efficacy of the fully human antibody panitumumab was evaluated in patients with metastatic colorectal cancer refractory to available therapies. ## METHODS. This phase 2 open‐label, multicenter study of panitumumab enrolled patients with metastatic colore

Quality of survival reporting in chemoth
Quality of survival reporting in chemotherapy and surgery trials in patients with metastatic colorectal carcinoma
✍ Robert C. G. Martin; Vedra A. Augenstein; Charles R. Scoggins; Kelly M. McMaster 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract ## BACKGROUND Patients with metastatic colorectal carcinoma (MCC) to the liver receive conflicting management recommendations because of the lack of prospective randomized controlled trials (RCTs) clarifying the optimal management in this disease. The oabjective of the current study wa